Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132080) titled 'Study on the Safety and Efficacy of Hyperbaric Oxygen Therapy for Severe Fever with Thrombocytopenia Syndrome' on Sept. 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Ditan Hospital, Capital Medical University

Condition: severe fever with thrombocytopenia syndrome

Intervention: Conventional treatment combined with HBO therapy group:1. Basic treatment (administered to both groups of patients) 2. Hyperbaric oxygen therapy as an adjunct treatment.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-09

Target Sample Size: Conventional tre...